Brief Articles
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Oct 14, 2009; 15(38): 4833-4837
Published online Oct 14, 2009. doi: 10.3748/wjg.15.4833
Table 1 Comparison of clinicopathological factors between LRP16 positive and LRP16 negative patients with gastric carcinoma n (%)
VariableLRP16
Statistics value
Positive group (n = 197)Negative group (n = 139)
Gender
Male165 (60.2)109 (39.8)χ2 = 1.544
Female32 (51.6)30 (48.4)P = 0.214
Age (yr)
≤ 4019 (55.9)15 (44.1)χ2 = 1.544
41-65114 (57.6)84 (42.4)P = 0.756
> 6564 (61.5)40 (38.5)
Tumor size (cm)
< 436 (46.8)41 (53.2)χ2 = 11.593
4-7117 (58.2)84 (41.8)P = 0.003a
≥ 844 (75.9)14 (24.1)
Histologic differentiation
Well differentiated8 (47.1)9 (52.9)χ2 = 1.165
Moderately differentiated40 (61.5)25 (38.5)P = 0.558
Poorly differentiated149 (58.7)105 (41.3)
Depth of invasion, T stage
T110 (43.5)13 (56.5)χ2 = 9.041
T255 (53.4)48 (46.6)P = 0.029a
T3113 (60.4)74 (39.6)
T419 (82.6)4 (17.4)
Lymph node metastasis
049 (44.1)62 (55.9)χ2 = 18.946
1-677 (60.2)51 (39.8)P = 0.000a
7-1549 (68.1)23 (31.9)
> 1521 (84.0)4 (16.0)
Distant metastasis
Negative182 (56.9)138 (43.1)χ2 = 8.543
Positive15 (93.8)1 (6.2)P = 0.003a
TNM stage
 I-II stage63 (44.1)80 (55.9)χ2 = 21.804
III-IV stage134 (69.4)59 (30.6)P = 0.000a